Comparing Outcomes: In-Person and Telehealth Oncology Visits
Vergleich der Outcomes: persönliche und telemedizinische onkologische Visiten
JCO Oncology Practice · 2026-11 · 22 (11) · 1986-1994
DOI: 10.1200/op-25-00616 ↗Auf einen Blick
In einer Beobachtungsstudie waren die meisten Nutzungs- und Qualitätsmaße nach Telehealth und Präsenzvisiten ähnlich. Nach Telehealth traten jedoch häufiger Follow-up-Präsenzvisiten nach 30 Tagen auf, und die wahrgenommene Privatsphäre war geringer.
Fragestellung
Unterscheiden sich Folgeinanspruchnahme, wahrgenommene Versorgungsqualität und Kommunikation zwischen telemedizinischen und persönlichen onkologischen Visiten?
Methode
Beobachtungs-Kohortenstudie mit Patienten ab 21 Jahren mit malignen Neoplasien; Propensity-Score-gewichtete Modelle mit Anpassung an patienten-, gesundheits- und census-tract-Merkmale.
Ergebnisse
487 Befragte (93 Telehealth, 394 in-person). Follow-up-Präsenzvisiten nach 30 Tagen: 64 % vs. 46 %; PD 0,18 (95 %-KI 0,07–0,28). Akutversorgung ohne signifikanten Unterschied; Privatsphäre: 80 % vs. 67 % (P < .01).
Schlussfolgerung der Autor:innen
Obwohl die meisten Gesundheitsnutzungs- und Patientenurteile ähnlich waren, sprechen die Befunde dafür, Telehealth als praktikable onkologische Option zu betrachten; Privatsphäre und geeignete Einsatzsituationen sollten berücksichtigt werden.
Kernaussagen
- Nach 30 Tagen häufiger Follow-up-Präsenzvisiten nach Telehealth
- Akute Versorgungsereignisse unterschieden sich nicht signifikant
- Wahrgenommene Privatsphäre war bei Telehealth geringer
Deutsche Zusammenfassung: KI-gestützt aus dem Original-Abstract erstellt; alle Zahlen wurden automatisch mit dem Original abgeglichen. Maßgeblich ist der Original-Abstract.
Kurz gefasst
Beobachtungsstudie in der Zeitschrift JCO Oncology Practice, 2026-11. Verfasst von Ilona Fridman und 11 weiteren Autor:innen. Beteiligte Einrichtung: University of North Carolina Lineberger Comprehensive Cancer Center, Chapel Hill, NC. Hauptthemen laut MEDLINE: Telemedicine, Neoplasms, Medical Oncology. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 54 Literaturangaben.
Themen: Digitalisierung in der Pflege
Abstract (Originalsprache)
PURPOSE Telemedicine offers significant benefits, but concerns regarding care quality persist. To inform future oncology telehealth policy, we compared subsequent health care use, patient-reported care quality, and communication outcomes between telehealth and in-person visits. METHODS An observational cohort study (April 2022-October 2023) included patients age 21+ years with malignant neoplasms, a scheduled oncology visit, and cancer treatment initiated 6 months to 3 years before the study. Black adults and those with telehealth visits were oversampled. Pre- and post-visit telephone survey data were joined with electronic health record data and geocoded community characteristics. Outcomes included subsequent acute care events (emergency department visits and unplanned hospitalizations), follow-up visits, patient perceptions of whether their care needs were met, and communication quality via validated instruments, with Likert-scale responses. We estimated prevalence differences (PDs) in outcomes by visit type using propensity score–weighted generalized linear models that adjusted for patient socioeconomic, health, and census tract–level differences. RESULTS After propensity score adjustments achieved covariate balance, 487 respondents (93 telehealth, 394 in-person) were included. Mean age was 64 (standard deviation = 13) years; 62% were female, 26% were Black, 82% had some college degree or more, and 25% reported fair/poor health. Follow-up in-person visits at 30 days were more frequent after telehealth (64%, 46%; PD = 0.18 [95% CI, 0.07 to 0.28]), with no differences at 7 or 14 days. Acute care use did not significantly differ at any time point. Quality and communication ratings were similar (PD range: 0.00-0.09), except for perceived privacy: 80% in-person, 67% telehealth, P < .01. CONCLUSION Although mostly similar health care use and patient perceptions suggest telehealth as a viable oncology option, identified differences highlight the need to ensure privacy and evaluate when telehealth visits are most appropriate.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- University of North Carolina Lineberger Comprehensive Cancer Center, Chapel Hill, NC.
- Department of Public Health Sciences, Henry Ford Health, Detroit, MI.
- Department of Epidemiology and Biostatistics, College of Human Medicine, Michigan State University, East Lansing, MI.
- University of North Carolina Eshelman School of Pharmacy, Chapel Hill, NC.
- Department of Health Policy and Management, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD.
- Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina, Chapel Hill, NC.
ORCID-Profile: Ilona Fridman, Matthew R Dunn, Alan C Kinlaw, Jacob N Stein, Samantha Tam, William A Wood, Soroush Fariman, Jennifer Elston Lafata
Zitieren
APA
Fridman, I., Neslund-Dudas, C., Barrow, L. J., Dunn, M. R., Jones, R., Kinlaw, A. C., Smith, A. B., Stein, J. N., Tam, S., Wood, W. A., Fariman, S., & Lafata, J. E. (2026). Comparing Outcomes: In-Person and Telehealth Oncology Visits. JCO Oncology Practice, 22(11), 1986-1994. https://doi.org/10.1200/op-25-00616
Vancouver
Fridman I, Neslund-Dudas C, Barrow LJ, Dunn MR, Jones R, Kinlaw AC, et al. Comparing Outcomes: In-Person and Telehealth Oncology Visits. JCO Oncology Practice. 2026;22(11):1986-1994. doi:10.1200/op-25-00616
BibTeX
@article{Fridman2026,
author = {Fridman, Ilona and Neslund-Dudas, Christine and Barrow, Lauren Jordan and Dunn, Matthew R and Jones, Regina and Kinlaw, Alan C and Smith, Angela B and Stein, Jacob N and Tam, Samantha and Wood, William A and Fariman, Soroush and Lafata, Jennifer Elston},
title = {Comparing Outcomes: In-Person and Telehealth Oncology Visits},
journal = {JCO Oncology Practice},
year = {2026},
volume = {22},
number = {11},
pages = {1986--1994},
doi = {10.1200/op-25-00616}
}
EUVIMED